Anti-Adiponectin antibody
Specifications
| Product Cat#: | AB-06-4898 |
| Product type: | Primary antibody |
| Antigen: | Adiponectin |
| Immunogen: | Recombinant protein within mouse Adiponectin aa 1-247/247. |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400) |
| Reactivity: | Mouse |
| Clonality (clone number): | Monoclonal, JE65-49 |
| Form: | Liquid |
| Buffer: | 1*TBS buffer (pH7.4), 0.05% BSA, 40% Glycerol, 0.05% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified. |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Conjugate: | Unconjugated |
| Alternative names: | 30 kDa adipocyte complement related protein antibody |
| 30 kDa adipocyte complement-related protein antibody | |
| ACDC antibody | |
| Acrp 30 antibody | |
| ACRP30 antibody | |
| ADIPO_HUMAN antibody | |
| Adipocyte antibody | |
| Adipocyte C1q and collagen domain containing protein antibody | |
| Adipocyte complement related 30 kDa protein antibody | |
| Adipocyte complement related protein of 30 kDa antibody | |
| Adipocyte complement-related 30 kDa protein antibody | |
| Adipocyte-specific secretory protein antibody | |
| Adiponectin antibody | |
| Adiponectin precursor antibody | |
| Adiponectin, C1Q and collagen domain containing antibody | |
| Adipoq antibody | |
| Adipose most abundant gene transcript 1 antibody | |
| Adipose most abundant gene transcript 1 protein antibody | |
| Adipose specific collagen like factor antibody | |
| ADIPQTL1 antibody | |
| ADPN antibody | |
| APM 1 antibody | |
| ApM-1 antibody | |
| APM1 antibody | |
| C1q and collagen domain-containing protein antibody | |
| GBP 28 antibody | |
| GBP28 antibody | |
| Gelatin binding protein antibody | |
| Gelatin binding protein 28 antibody | |
| Gelatin-binding protein 28 antibody | |
| Gelatin-binding protein antibody | |
| OTTHUMP00000210047 antibody |
Target information
Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW.
Provider
Erpantech Laboratory
